Christopher D. Sarsons

Tailoring nanoparticle designs to target cancer based on tumor pathophysiology

Edward A. Sykes, Qin Dai, Christopher D. Sarsons et al. · Proceedings of the National Academy of Sciences · 2016 · 271 citations · Full text

Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism

Laura Tsujikawa, Li Fu, Shovon Das et al. · Clinical Epigenetics · 2019 · 117 citations · Full text

Apabetalone downregulates factors and pathways associated with vascular calcification

Dean Gilham, Laura Tsujikawa, Christopher D. Sarsons et al. · Atherosclerosis · 2018 · 65 citations · Full text

Surface-grafted polyethylene glycol conformation impacts the transport of PEG-functionalized liposomes through a tumour extracellular matrix model

Hagar I. Labouta, Christopher D. Sarsons, Trinh Nguyen et al. · RSC Advances · 2018 · 57 citations · Full text

Tissue Engineering, Nanomedicine, Collagen Matrix +14

Quantum dot interactions and flow effects in angiogenic zebrafish ( Danio rerio ) vessels and human endothelial cells

Xiaoyu Jiang, Christopher D. Sarsons, David T. Cramb et al. · Nanomedicine Nanotechnology Biology and Medicine · 2016 · 29 citations · Full text